Discover new products using enzyme research. Increase production and lower costs. Improve quality. By combining C1 technology with Dyadic’s enzyme expertise, researchers in the burgeoning nutraceuticals industry can advance the discovery, innovation, production and manufacturing of new products.
Creating products of value
Nutraceuticals are still in their formative years, but the future is bright and profitable for companies who develop therapeutic products of value. Dyadic believes that its integrated C1 technology platform will play a major role in delivering functionally superior new ingredients for nutraceuticals, which deliver true value to consumers when they use dietary supplements, herbal products, and processed foods such as cereals, soups and beverages.
Dyadic welcomes collaboration with companies in the health industries to discover, develop and manufacture unique and exclusive products to satisfy the unmet needs of this large and attractive market segment. Dyadic depends on its business partners to help define product and ingredient targets where its powerful C1 discovery and expression technology can be beneficially applied to create truly differentiated products of higher health and therapeutic value for consumers.
Products for Nutraceuticals
Dyadic® Beta Glucanase BP CONC – is a concentrated powder acid beta-1,3-1,4-glucanase/cellulase (E.C. 220.127.116.11) product by the fermentation of non-GMO Trichoderma longibrachiatum.
SDS BETA GLUCANASE BP CONC
Dyadic® Xylanase 2XP CONC – is a concentrated powder acid-neutral endo-1,4-β-D-xylanase (E.C. 18.104.22.168) produced by the fermentation of non-GMO Trichoderma longibrachiatum.
Xylanase 2XP CONC
SDS XYLANASE 2XP CONC